UMIN ID: C000000255
Registered date:01/10/2005
Additional JET Study for Patients during Maintenance Phase(Co-JET Study)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | maintenance-phase renal failure (predialysis renal failure) |
| Date of first enrollment | 2005/10/01 |
| Target sample size | 3000 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Risk analysis of background factors affecting vital prognosis following initiation of hemodialysis is performed by the appropriate technique, such as Cox's regression model. |
|---|---|
| Secondary Outcome | Additionally, the same analysis is carried out with hospitalization as is done for vital prognosis. |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | no criteria |
Related Information
| Primary Sponsor | Scientific Advisory Committee (SAC) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | CHUGAI PHARMACEUTICAL CO.LTD. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | SHIGERU NIHOJIMA |
| Address | 1-1MUROMACHI 2-CHOME, CHUO-KU TOKYO #103-8324, JAPAN Japan |
| Telephone | 03-3273-0773 |
| nihojimasgr@chugai-pharm.co.jp | |
| Affiliation | Chugai Pharmaceutical CO.LTD. PHARMACOVIGILANCE Dept. |
| scientific contact | |
| Name | SYUNJI YOKOYAMA |
| Address | 1-1MUROMACHI 2-CHOME, CHUO-KU TOKYO #103-8324, JAPAN Japan |
| Telephone | 03-3273-0773 |
| udagawayko@chugai-Pharm.co.jp | |
| Affiliation | Chugai Pharmaceutical CO.LTD. Drug Safety Unit |